Paliperidone Palmitate Every Three Months (PP3M) 2-Year Treatment Compliance, Effectiveness and Satisfaction Compared with Paliperidone Palmitate-Monthly (PP1M) in People with Severe Schizophrenia

Paliperidone palmitate every three months (PP3M) is expected to facilitate patient’s treatment compliance and satisfaction. The objective here was to compare PP3M treatment compliance and satisfaction, effectiveness and tolerability, with paliperidone palmitate-monthly (PP1M) in patients with severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Miranda, Juan J., Díaz-Fernández, Silvia, De Berardis, Domenico, López-Muñoz, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036785/
https://www.ncbi.nlm.nih.gov/pubmed/33915786
http://dx.doi.org/10.3390/jcm10071408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036785/
https://www.ncbi.nlm.nih.gov/pubmed/33915786
http://dx.doi.org/10.3390/jcm10071408

Ejemplares similares